Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Post by moneywagonon Oct 13, 2022 3:11pm
99 Views
Post# 35023125

BIOV WE BEAT YESTERDAYS VOLUME OVER 600K

BIOV WE BEAT YESTERDAYS VOLUME OVER 600K
C:BIOV - BioVaxys Technology Corp. - https://biovaxys.com
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
BIOV - C   5.5 0.185 · 0.195 9.0 0.19 +0.005 2.7 633.3 105 154 0.19  0.20  0.15 0.465  0.085 14:45:17 Oct 06 15 min RT 2¢
CSE - C 5.5 0.185 · 0.195 9.0 0.19 +0.005 2.7 309.4 50 89 0.19  0.195  0.155 0.465  0.085 14:45:17   15 min
NEO ATS - U   0.19 +0.005 2.7 255.0 43 45 0.195  0.20  0.15   14:43:25   15 min
Omega - O   0.19 +0.005 2.7 63.5 11 9 0.19  0.19  0.16   14:43:25   15 min
CX2 - H   0.165 -0.02 -10.8 4.3 0 5 0.15  0.165  0.15   12:02:28   15 min
TriAct - M   0.185     1.1   6            15 min

Close Prices Last 3 Months

Date Ex Sym Open High Low Close Chg Total Vol #Tr Bid Ask C-CSE U-NEO ATS A-Alpha O-Omega P-Pure X-Chi-X H-CX2 D-CXD L-LiquidNet M-TriAct I-Instinet Y-Lynx
2022-10-12 C BIOV 0.22 0.22 0.17 0.185 -0.035 479,860 178 0.18 0.20 278,611 92,500   99,000   2,000 5,000     2,241    
2022-10-11 C BIOV 0.225 0.255 0.215 0.22 -0.01 917,722 276 0.22 0.23 495,674 231,000   140,500   6,000 25,500     18,652    
2022-10-07 C BIOV 0.17 0.255 0.145 0.23 0.055 1,889,019 421 0.225 0.25 1,343,232 312,000   143,000   45,898 41,500     2,523    
2022-10-06 C BIOV 0.215 0.27 0.17 0.175 -0.03 2,243,372 678 0.17 0.18 1,308,886 602,000   267,000   8,500 49,500     6,086    
2022-10-05 C BIOV 0.12 0.21 0.115 0.205 0.10 1,296,692 354 0.205 0.22 840,822 306,500   83,000   5,000 57,103     4,267    
2022-10-04 C BIOV 0.115 0.115 0.105 0.115 -0.005 30,353 20 0.11 0.12 24,500 3,000         1,500     425

<< Previous
Bullboard Posts
Next >>